KIRIN PHARMA

(Based on 44e) biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemical reagents for non-medical and non-veterinary purposes

(Based on 44e) pharmaceutical preparations for the treatment of anemia, leukopenia, thrombocytopenia, hyperphosphatemia, hyperparathyroidism, cancer, leukemia, influenza, HIV, myelodysplastic syndrome, infectious diseases, autoimmune diseases; pharmaceutical preparations for mobilization of peripheral blood progenitor cells; pharmaceutical preparations for conditioning treatment prior to hematopoietic stem cell transplantation; diagnostic agents, preparations and substances for medical and veterinary use; pre-filled syringes filled with pharmaceutical preparations for the treatment of anemia, leucopenia, thrombocytopenia, mobilization of peripheral blood progenitor cell, hyperphosphatemia, hyperparathyroidism, cancer, leukemia, influenza, HIV, myelodysplastic syndrome, infectious diseases and autoimmune diseases, and for conditioning treatment prior to hematopoietic stem cell transplantation

(Based on 44e) syringes for medical purposes; injection devices for pharmaceuticals; injection needles; blood transfusion apparatus or devices; infusion apparatus or devices for therapeutic purposes

(Based on Use in Commerce) patent licensing; development of new technology for others in the field of human antibodies and biotechnology; medical research